Uncategorized
Relay Therapeutics® to Present at 39th Annual J.P. Morgan Healthcare Conference
Read More
Relay Therapeutics Extends Leadership in Integrating Computational and Experimental Approaches to Create Precision Medicines by Acquiring ZebiAI
Together, Relay Therapeutics and ZebiAI aspire to accelerate the application of machine learning across the Dynamo™ platform to potentially fast-track the finding of novel medicines against intractable targets.
Traditional drug discovery is like looking at old black and white photos. Our approach enables us to visualize protein motion in HD movies.
DynamoTM Platform
By leveraging our leading-edge experimental and computational approaches, we aim to more effectively drug targets that have previously been intractable or inadequately drugged.
Relay Therapeutics® is creating new possibilities in drug discovery.
Pipeline
We aim to drug the undruggable.
We are advancing a pipeline of promising therapeutic candidates, with an initial focus on precision oncology.
Because you
can’t wait.
Patients
We are laser-focused on bringing life-changing medicines to patients. Find out if our clinical trials may be right for you.
Who We Are
Equal parts bright and bold,
our world-class team is highly integrated, collaborative and entrepreneurial.
Relentless
Fearless
Humanity
Find a career at Relay Therapeutics that’s right for you.
Careers